仟源医药股东翁占国拟减持不超3%股份

Core Viewpoint - The shareholder Weng Zhangguo of Qianyuan Pharmaceutical plans to reduce his stake in the company by up to 7.6831 million shares, representing no more than 3% of the total share capital, through centralized bidding and block trading from November 13, 2025, to February 12, 2026 [1] Summary by Relevant Sections - Shareholder Reduction Plan - Weng Zhangguo intends to reduce his holdings by a maximum of 7.6831 million shares [1] - This reduction will account for up to 3% of the company's total share capital [1] - The planned timeframe for this reduction is from November 13, 2025, to February 12, 2026 [1]